Effects of calcium and cyclic nucleotides on rat calcitonin and parathyroid hormone secretion.
Recently we developed a system for studying concurrent secretion of calcitonin (CT)and parathyroid hormone(PTH)in vitro from single rat thyroparathyroid gland complexes. In the present study, mechanisms involved in secretion of CT and PTH were explored by altering the medium [Ca ] and by using the Ca antagonist, verapamil. We also re-examined the idea that cyclic nucleotides may help regulate secretion of these hormones and attempted to determine if effects of cyclic nucleotides might be altered by changes in medium [Ca]. Thyroparathyroid glands from 8-day-old rats were incubated in serum-free medium for 8h, and CT and PTH levels in the medium were measured by radioimmunoassays. We show for the first time that: (1) although low [Ca] is well known to promote PTH release, some extracellular Ca is needed for PTH secretion to occur at a maximal rate; (2) inhibition of Ca entry into cells with verapamil mimics the effects of low medium Ca on both CT and PTH release; and (3) cyclic nucleotides may exert their effects on secretion of CT and PTH at least in part via effects on Ca entry into cells.
D000818:Animals; D000831:Animals, Newborn; D001681:Biological Assay; D003994:Bucladesine / Q000494:pharmacology*; D002116:Calcitonin / Q000378:metabolism*; D002118:Calcium / Q000494:pharmacology*; D006152:Cyclic GMP / Q000031:analogs & derivatives*; D003995:Dibutyryl Cyclic GMP / Q000494:pharmacology*; D007461:Iodoacetates / Q000494:pharmacology; D010280:Parathyroid Glands / Q000187:drug effects; D010281:Parathyroid Hormone / Q000378:metabolism*; D051381:Rats; D013997:Time Factors; D014700:Verapamil / Q000494:pharmacology
D007461:Iodoacetates; D010281:Parathyroid Hormone; D003995:Dibutyryl Cyclic GMP; D003994:Bucladesine; D002116:Calcitonin; D014700:Verapamil; D006152:Cyclic GMP; D002118:Calcium